Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000117

Options or other derivatives

  • Chief Financial Officer acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tan Kevin · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-20 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +750,000 750,000 D
Loading xslF345X03/wf-form4_163234196808903.xml…